OceanFirst faces earnings today with short interest up a third in 30 days. Call-buying has dried up, signaling caution among options traders.
Short interest stands at 8.98% of float as of April 22.
That's up 33% over the past month. The jump accelerated in early April, when shares shorted climbed from 4.4 million to 5.2 million in a single session. Since then positioning has held steady. Days to cover sits at 6.2, giving shorts meaningful cushion. Cost to borrow remains negligible at 0.47%, down slightly over the past week. Utilisation is low at 11%, well below the 52-week peak of 31%. Borrowing remains easy.
The put/call ratio collapsed to 0.01 on April 23, the lowest reading in 52 weeks.
That marks extreme call dominance. But the 20-day average PCR is 0.13, and recent history shows steady put buying through mid-April. The current Z-score of –2.34 indicates a sharp break from recent norms. Call volume spiked into the print, a pattern typical of short-dated bullish bets. No implied move data is available.
No analyst rating or price target data is available for OCFC.
Coverage appears limited. The stock trades at $19.06, up 1.5% over the past week and 6.6% over the past month. That outperformance comes despite rising short interest. Market cap data is unavailable, but the stock sits in the regional banks sector.
The company last reported earnings on January 23, 2026.
Today's print was announced on April 2. Prior earnings calls occurred in October 2025 and earlier in 2026. No post-earnings price reaction data is included in the snapshot. The earnings time is set for 3:00 PM ET today.
No active ORTEX Alpha signals are present.
The ORTEX short score sits at 57.1, a moderate reading. That score has held in the mid-to-upper 50s over the past two weeks, reflecting stable but elevated short positioning. The combined score mirrors the short score at 57.1.
See the live data behind this article on ORTEX.
Open OCFC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
